Merck & Co.'s Barr To Lead Clinical Development After Baynes Departs For Eikon

Longtime R&D leader Roy Baynes is leaving Merck to become chief medical officer at the biotech start-up helmed by Merck's former R&D chief Roger Perlmutter.